Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Genitourinary System Carcinoma clinical trials
3 of 4 indexed Genitourinary System Carcinoma trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Genitourinary System Carcinoma: 4 US clinical trials tracked, 3 recruiting.
Genitourinary System Carcinoma is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is University of Michigan Rogel Cancer Center, running 1 of these trials.
Enrollment posture brief
Registry condition genitourinary-system-carcinoma
OPEN 3 | RECR 75% | LATE 0 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Genitourinary System Carcinoma lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Genitourinary System Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Genitourinary System Carcinoma is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
M.D. Anderson Cancer Center
NCT00991094
Cancer Genetic Testing in Ethnic Populations
Mayo Clinic
NCT04475640
Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System
University of Michigan Rogel Cancer Center
NCT07219134
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
City of Hope Medical Center
NCT04596384
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Genitourinary System Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Genitourinary System Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Genitourinary System Carcinoma page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Genitourinary System Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Michigan Rogel Cancer Center sponsors the most Genitourinary System Carcinoma trials on record, review their full trial history before evaluating a specific study. See University of Michigan Rogel Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Genitourinary System Carcinoma condition card totals 4 registered trials; most-linked intervention Quality-of-Life Assessment; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.